Browsing by Author "Batla, Amit (36450181000)"
Now showing 1 - 6 of 6
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Cerebellar and Midbrain Lysosomal Enzyme Deficiency in Isolated Dystonia(2022) ;Schreglmann, Sebastian R. (53867273100) ;Burke, Derek (7403246896) ;Batla, Amit (36450181000) ;Kresojevic, Nikola (26644117100) ;Wood, Nicholas (7202960784) ;Heales, Simon (7005146428)Bhatia, Kailash P. (25958636400)[No abstract available] - Some of the metrics are blocked by yourconsent settings
Publication Cerebellar and Midbrain Lysosomal Enzyme Deficiency in Isolated Dystonia(2022) ;Schreglmann, Sebastian R. (53867273100) ;Burke, Derek (7403246896) ;Batla, Amit (36450181000) ;Kresojevic, Nikola (26644117100) ;Wood, Nicholas (7202960784) ;Heales, Simon (7005146428)Bhatia, Kailash P. (25958636400)[No abstract available] - Some of the metrics are blocked by yourconsent settings
Publication European Academy of Neurology (EAN)/European Federation of Autonomic Societies (EFAS)/International Neuro-Urology Society (INUS) Guidelines for Practising Neurologists on the Assessment and Treatment of Neurogenic Urinary and Sexual Symptoms (NEUROGED Guidelines)(2025) ;Panicker, Jalesh N. (8862148900) ;Fanciulli, Alessandra (37072222700) ;Skoric, Magdalena Krbot (57200385145) ;Kaplan, Tamara (56715235200) ;Aleksovska, Katina (58308295100) ;Adamec, Ivan (41261161500) ;Averbeck, Marcio Augusto (24775312700) ;Campese, Nicole (57209836317) ;Guaraldi, Pietro (6506466690) ;Leys, Fabian (57216857911) ;Moreno-Palacios, Jorge (35722499200) ;Simeoni, Sara (6701483309) ;Stankovic, Iva (58775209600) ;Wright, Sarah (57463008300) ;Batla, Amit (36450181000) ;Blok, Bertil (7006333211) ;Hentzen, Claire (57194279175) ;Hilz, Max Josef (7005993594) ;Kessler, Thomas M. (7006782097) ;Madersbacher, Helmut (7004903487) ;Nair, Kannan Rajasekharan (58419982200) ;Nair, Krishnan Padmakumari Sivaraman (7201447568) ;Pakzad, Mahreen (57189294591) ;Traon, Anne Pavy-Le (57202460030) ;Peryer, Guy (8944272600) ;Przydacz, Mikolaj (56910210200) ;Sakakibara, Ryuji (7102769780) ;Saraf, Udit (57191379313) ;Smith, Matthew (57201058329) ;Struhal, Walter (55883219000) ;Thijs, Roland D. (8906436400) ;Tudor, Katarina Ivana (8692298900) ;Tutaj, Marcin (10040727500) ;Vodušek, David B. (7006377342) ;Wenning, Gregor (21647300300)Habek, Mario (14050219000)Background: Urinary and sexual symptoms are common following neurological disease, and we aimed to develop multidisciplinary inter-society evidence-based management guidelines. Methods: The ADAPTE framework was used, and a systematic search of guidelines published in different languages was performed. Guidelines, consensus statements, and systematic reviews were included, and guideline quality was appraised using AGREE II. Patient representatives reviewed the relevance and suitability of recommendations. A modified Delphi process integrating the Evidence to Decision framework adapted from GRADE and the Oxford Centre for Evidence Based Medicine system was used to reach consensus on recommendation wording and strength. Results: Recommendations were drafted, using guidelines/consensus statements (59 urinary, 50 sexual), systematic reviews (8 urinary, 2 sexual) and others (7 urinary,13 sexual), and wordings/strengths achieved at least 80% consensus through 2 Delphi rounds. Eleven evidence-based recommendations, 19 good practice statements, and 8 consensus-based recommendations were made. Individuals with neurological diseases should be asked about urogenital symptoms and undergo targeted physical examination when appropriate. Urinary symptom assessments include urinalysis, bladder diary completion, and post-void residual volume measurement. Treatments include fluid intake optimization, pelvic physiotherapy, tibial nerve stimulation, and oral medications. Urinary retention is managed by intermittent catheterization. Antibiotics should not be recommended to treat asymptomatic bacteriuria. Suprapubic catheterization is preferred for long-term catheterization. A comprehensive sexual history should be taken, focusing on multidimensional factors affecting sexual health. Treatments include lubricants, vibrators, and phosphodiesterase-5 inhibitors. Red flag symptoms warrant a shared-care approach with specialist colleagues. Conclusions: The 38 NEUROGED recommendations will guide neurologists to comprehensively manage urogenital symptoms reported by individuals with neurological diseases. © 2025 The Author(s). European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology. - Some of the metrics are blocked by yourconsent settings
Publication European Academy of Neurology (EAN)/European Federation of Autonomic Societies (EFAS)/International Neuro-Urology Society (INUS) Guidelines for Practising Neurologists on the Assessment and Treatment of Neurogenic Urinary and Sexual Symptoms (NEUROGED Guidelines)(2025) ;Panicker, Jalesh N. (8862148900) ;Fanciulli, Alessandra (37072222700) ;Skoric, Magdalena Krbot (57200385145) ;Kaplan, Tamara (56715235200) ;Aleksovska, Katina (58308295100) ;Adamec, Ivan (41261161500) ;Averbeck, Marcio Augusto (24775312700) ;Campese, Nicole (57209836317) ;Guaraldi, Pietro (6506466690) ;Leys, Fabian (57216857911) ;Moreno-Palacios, Jorge (35722499200) ;Simeoni, Sara (6701483309) ;Stankovic, Iva (58775209600) ;Wright, Sarah (57463008300) ;Batla, Amit (36450181000) ;Blok, Bertil (7006333211) ;Hentzen, Claire (57194279175) ;Hilz, Max Josef (7005993594) ;Kessler, Thomas M. (7006782097) ;Madersbacher, Helmut (7004903487) ;Nair, Kannan Rajasekharan (58419982200) ;Nair, Krishnan Padmakumari Sivaraman (7201447568) ;Pakzad, Mahreen (57189294591) ;Traon, Anne Pavy-Le (57202460030) ;Peryer, Guy (8944272600) ;Przydacz, Mikolaj (56910210200) ;Sakakibara, Ryuji (7102769780) ;Saraf, Udit (57191379313) ;Smith, Matthew (57201058329) ;Struhal, Walter (55883219000) ;Thijs, Roland D. (8906436400) ;Tudor, Katarina Ivana (8692298900) ;Tutaj, Marcin (10040727500) ;Vodušek, David B. (7006377342) ;Wenning, Gregor (21647300300)Habek, Mario (14050219000)Background: Urinary and sexual symptoms are common following neurological disease, and we aimed to develop multidisciplinary inter-society evidence-based management guidelines. Methods: The ADAPTE framework was used, and a systematic search of guidelines published in different languages was performed. Guidelines, consensus statements, and systematic reviews were included, and guideline quality was appraised using AGREE II. Patient representatives reviewed the relevance and suitability of recommendations. A modified Delphi process integrating the Evidence to Decision framework adapted from GRADE and the Oxford Centre for Evidence Based Medicine system was used to reach consensus on recommendation wording and strength. Results: Recommendations were drafted, using guidelines/consensus statements (59 urinary, 50 sexual), systematic reviews (8 urinary, 2 sexual) and others (7 urinary,13 sexual), and wordings/strengths achieved at least 80% consensus through 2 Delphi rounds. Eleven evidence-based recommendations, 19 good practice statements, and 8 consensus-based recommendations were made. Individuals with neurological diseases should be asked about urogenital symptoms and undergo targeted physical examination when appropriate. Urinary symptom assessments include urinalysis, bladder diary completion, and post-void residual volume measurement. Treatments include fluid intake optimization, pelvic physiotherapy, tibial nerve stimulation, and oral medications. Urinary retention is managed by intermittent catheterization. Antibiotics should not be recommended to treat asymptomatic bacteriuria. Suprapubic catheterization is preferred for long-term catheterization. A comprehensive sexual history should be taken, focusing on multidimensional factors affecting sexual health. Treatments include lubricants, vibrators, and phosphodiesterase-5 inhibitors. Red flag symptoms warrant a shared-care approach with specialist colleagues. Conclusions: The 38 NEUROGED recommendations will guide neurologists to comprehensively manage urogenital symptoms reported by individuals with neurological diseases. © 2025 The Author(s). European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology. - Some of the metrics are blocked by yourconsent settings
Publication The clinical syndrome of dystonia with anarthria/aphonia(2016) ;Ganos, Christos (37101265800) ;Crowe, Belinda (56148885300) ;Stamelou, Maria (57208560010) ;Kresojević, Nikola (26644117100) ;Lukić, Milica Ječmenica (35801126700) ;Bras, Jose (57220530727) ;Guerreiro, Rita (57200994996) ;Taiwo, Funmilola (57000272100) ;Balint, Bettina (25642482400) ;Batla, Amit (36450181000) ;Schneider, Susanne A. (14036326000) ;Erro, Roberto (36008087300) ;Svetel, Marina (6701477867) ;Kostić, Vladimir (57189017751) ;Kurian, Manju A. (26647482400)Bhatia, Kailash P. (25958636400)Objectives: In dystonia the formulation of a clinical syndrome is paramount to refine the list of etiologies. We here describe the rare association of dystonia with anarthria/aphonia, by examining a large cohort of patients, to provide a narrow field of underlying conditions and a practical algorithmic approach to reach diagnosis. Methods: We retrospectively reviewed cases, which were evaluated between 2005 and 2014, to identify those with dystonia combined with marked anarthria and/or aphonia. We reviewed demographic information, clinical characteristics, as well as clinico-genetic investigations. We evaluated video material where available. Results: From 860 cases with dystonia as the predominant motor feature, we identified 32 cases (3.7%) with anarthria/aphonia. Age at neurological symptom onset was variable, but the majority of cases (n = 20) developed symptoms within their first eight years of life. A conclusive diagnosis was reached in 27 cases. Monoamine neurotransmitter disorders, neurodegeneration with brain iron accumulation syndromes, hypomyelination with atrophy of the basal ganglia and cerebellum, and syndromes with inborn errors of metabolism were the most common diagnoses. Brain MRI was crucial for reaching a diagnosis by examining the structural integrity of the basal ganglia, the cerebral cortex, brain myelination and whether there was abnormal metal deposition. Pathophysiological mechanisms underlying anarthria/aphonia included dystonia, corticobulbar involvement, apraxia and abnormalities of brain development. Conclusions: The spectrum of conditions that may present with the syndrome of dystonia with anarthria/aphonia is broad. Various causes may account for the profound speech disturbance. A practical brain MRI-based algorithm is provided to aid the diagnostic procedure. © 2016 Elsevier Ltd. - Some of the metrics are blocked by yourconsent settings
Publication The clinical syndrome of dystonia with anarthria/aphonia(2016) ;Ganos, Christos (37101265800) ;Crowe, Belinda (56148885300) ;Stamelou, Maria (57208560010) ;Kresojević, Nikola (26644117100) ;Lukić, Milica Ječmenica (35801126700) ;Bras, Jose (57220530727) ;Guerreiro, Rita (57200994996) ;Taiwo, Funmilola (57000272100) ;Balint, Bettina (25642482400) ;Batla, Amit (36450181000) ;Schneider, Susanne A. (14036326000) ;Erro, Roberto (36008087300) ;Svetel, Marina (6701477867) ;Kostić, Vladimir (57189017751) ;Kurian, Manju A. (26647482400)Bhatia, Kailash P. (25958636400)Objectives: In dystonia the formulation of a clinical syndrome is paramount to refine the list of etiologies. We here describe the rare association of dystonia with anarthria/aphonia, by examining a large cohort of patients, to provide a narrow field of underlying conditions and a practical algorithmic approach to reach diagnosis. Methods: We retrospectively reviewed cases, which were evaluated between 2005 and 2014, to identify those with dystonia combined with marked anarthria and/or aphonia. We reviewed demographic information, clinical characteristics, as well as clinico-genetic investigations. We evaluated video material where available. Results: From 860 cases with dystonia as the predominant motor feature, we identified 32 cases (3.7%) with anarthria/aphonia. Age at neurological symptom onset was variable, but the majority of cases (n = 20) developed symptoms within their first eight years of life. A conclusive diagnosis was reached in 27 cases. Monoamine neurotransmitter disorders, neurodegeneration with brain iron accumulation syndromes, hypomyelination with atrophy of the basal ganglia and cerebellum, and syndromes with inborn errors of metabolism were the most common diagnoses. Brain MRI was crucial for reaching a diagnosis by examining the structural integrity of the basal ganglia, the cerebral cortex, brain myelination and whether there was abnormal metal deposition. Pathophysiological mechanisms underlying anarthria/aphonia included dystonia, corticobulbar involvement, apraxia and abnormalities of brain development. Conclusions: The spectrum of conditions that may present with the syndrome of dystonia with anarthria/aphonia is broad. Various causes may account for the profound speech disturbance. A practical brain MRI-based algorithm is provided to aid the diagnostic procedure. © 2016 Elsevier Ltd.
